Non Small Cell Lung Cancer
Showing NaN - NaN of 45
Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,
Recruiting
- Small Cell Lung Cancer
- +4 more
- PF-07104091 monotherapy dose escalation
- +8 more
-
Clive, Iowa
- +22 more
Apr 26, 2022
Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +4 more
-
Aurora, Colorado
- +2 more
Apr 18, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)
Active, not recruiting
- Non Small Cell Lung Cancer
- Nivolumab
- +8 more
-
Glendale, Arizona
- +135 more
Feb 28, 2022
Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)
Melanoma, Non Small Cell Lung Cancer Trial in United States (enoblituzumab plus ipilimumab)
Completed
- Melanoma
- Non Small Cell Lung Cancer
- enoblituzumab plus ipilimumab
-
Los Angeles, California
- +9 more
Feb 4, 2022
Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +12 more
-
Nashville, Tennessee
- +4 more
Feb 3, 2022
Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- GRT-C901
- +3 more
-
Phoenix, Arizona
- +10 more
Aug 31, 2021
Non Small Cell Lung Cancer Trial in Worldwide (OSE2101, Docetaxel, Pemetrexed)
Active, not recruiting
- Non Small Cell Lung Cancer
- OSE2101
- +2 more
-
Burbank, California
- +76 more
Mar 5, 2021
Non Small Cell Lung Cancer, Cancer Trial in United States (Venetoclax, Pembrolizumab)
Terminated
- Non Small Cell Lung Cancer
- Cancer
-
Birmingham, Alabama
- +38 more
Feb 10, 2021
Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Pembrolizumab)
Terminated
- Non Small Cell Lung Cancer
- Pegilodecakin
- Pembrolizumab
-
Huntsville, Alabama
- +73 more
Jan 15, 2021
Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Nivolumab)
Detecting EGFR T790M Mutations From Circulating Tumor Cells
Completed
- Non Small Cell Lung Cancer
- Circulating tumor cell chip
-
Boston, Massachusetts
- +3 more
Sep 23, 2016
Non Small Cell Lung Cancer Trial in Worldwide (ARQ 197, Erlotinib, Placebo)
Completed
- Non Small Cell Lung Cancer
- ARQ 197
- +2 more
-
Burbank, California
- +37 more
Feb 22, 2013